A FUNCTIONAL PERSONALISED ONCOLOGY APPROACH AGAINST METASTATIC COLORECTAL CANCER IN MATCHED PATIENT DERIVED ORGANOIDS

A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids

Abstract Globally, colorectal cancer (CRC) is the third most frequently occurring cancer.Progression on to an advanced metastatic malignancy (metCRC) is often indicative of poor prognosis, as the 5-year survival rates of patients decline rapidly.Despite the availability of many systemic therapies for the management of metCRC, the long-term efficaci

read more

Molecular subtyping and functional validation of TTK, TPX2, UBE2C, and LRP8 in sensitivity of TNBC to paclitaxel

Triple-negative breast cancer (TNBC) patients exhibit variable responses to chemotherapy, suggesting an underlying molecular Face and body oil heterogeneity.In the current study, we analyzed publicly available transcriptome data from 360 TNBC and 88 normal breast tissues, which revealed activation of nucleosome and cell cycle as the hallmarks of TN

read more

POSSIBILITIES OF REGENERATION OF THE MUSCLES OF THE SOFT PALATE DURING ITS NONUNION DEPENDING ON THE MYOGENIC POTENTIAL OF STEM CELLS. Review

Relevance.Today there are more than 150 methods for eliminating congenital defects of the hard and soft palate.However, these techniques do not always lead to high functional results, which leads to repeated surgical interventions and long-term speech therapy rehabilitation.Therefore, there is a problem with Capo the prognosis of such treatment.The

read more


Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition

Abstract Background The combined use of a FGFR1 blocker and aromatase inhibitors is appealing for treating breast cancer patients with FGFR1 amplification.However, no pharmacodynamic studies have addressed the effects of this combined target modulation.We conducted a phase 0/I clinical trial in an adjuvant setting, with the goal of obtaining pharma

read more